GALECTIN THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Galectin Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • Galectin Therapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 62.2M shares, a 4.45% increase year-over-year.
  • Galectin Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60.2M shares, a 1.29% increase from 2022.
  • Galectin Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 59.4M shares, a 1.48% increase from 2021.
  • Galectin Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 58.5M shares, a 2.63% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 62.2M +2.65M +4.45% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 62M +2.5M +4.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 60.2M +768K +1.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 59.7M +308K +0.52% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 59.6M +193K +0.33% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 59.5M +126K +0.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 59.4M +864K +1.48% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 59.4M +106K +0.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 59.4M +1.08M +1.85% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 59.4M +2.22M +3.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 58.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 59.3M +2.24M +3.93% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 58.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 57.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 57M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.